Loading [Contrib]/a11y/accessibility-menu.js

Management of Pharmacotoxicologic Side Effects using Novel SONAPS Technologies

Short Commination | DOI: https://doi.org/10.31579/2693-7247/054

Management of Pharmacotoxicologic Side Effects using Novel SONAPS Technologies

  • Hosein Najafpour 1
  • Bahram Alamdary Badlou 2*

1 SONAPS Clinic. Research and Development Dept. Tehran, Iran

2 BB Advies and Research, Research and development Dept. Zeist, The Netherlands.

*Corresponding Author: Bahram Alamdary Badlou (CEO), BBAdvies and Research, Research and Development Dept. Zeist, The Netherlands.

Citation: Hosein Najafpour and Bahram Alamdary Badlou (2022) Management of Pharmacotoxicologic Side Effects using Novel SONAPS Technologies. J. Pharmaceutics and Pharmacology Research, 5(5); DOI:10.31579/2693-7247/054

Copyright: © 2022 Bahram Alamdary Badlou, This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: 28 February 2022 | Accepted: 10 March 2022 | Published: 10 April 2022

Keywords: pharmacotoxicologic; drugs

Abstract

Patients who are daily suffering from drug abuse and pharmacotoxicologic side effects causing unnecessary hospitals’ visits, which unintentionally increase morbidity and mortality rate in- Hospital that the underlying mechanism still is not elucidate completely

References

a